Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Bacterial ghosts (BGs) represent an innovative platform that exploits empty Gram‐negative bacterial envelopes produced through controlled lysis. These envelopes retain the native antigenic ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never ...

UVA Health scientists have developed a promising new way to create vaccines that could be faster, cheaper and easier to distribute than current options. The University of Virginia School of Medicine’s ...

Spread the loveThe Quest for a Durable Influenza Vaccine The annual struggle against the flu virus could soon see a transformative shift, thanks to groundbreaking research at the Texas Biomedical ...

If a second "novel coronavirus disease (COVID-19)" were to emerge, would we have to endure staying at home again while ...

The Food and Drug Administration’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes. The first sign of trouble was the ...

ProMIS Neurosciences Inc., a clinical-stage biotechnology firm, announced its plan to present preclinical data on novel computationally-derived vaccines targeting neurodegenerative diseases at the ...

The professor also dismissed claims that procurement through Unicef had been halted, calling such assertions “incorrect.” ...